Literature DB >> 6235074

Paradoxical presence of T cell anergy during successful T cell-dependent tumour immunotherapy: characterization of a state of T cell 'amnaesia' following systemic administration of C. parvum.

W H McBride, S Howie.   

Abstract

Systemic administration of Corynebacterium parvum causes T cell-dependent regression of an established methylcholanthrene-induced murine fibrosarcoma beginning 10 days after Cp injection. At this time, tumour specific effector T cell responses measured by reactivity in a T helper cell assay or in a Winn assay disappear only to return later. We refer to this temporary lapse in T cell reactivity as immunological 'amnaesia'. Antigen specific T cell responses within all lymphoid organs appear to be affected. The 'amnaesic' state is characterised by the presence of primed T cells but the absence of T effector cells and suppressor cells. The differentiation of the primed T cells is blocked probably as a result on the non-delivery of a differentiation signal. There are several possible mechanisms which could account for this; the one we prefer is that cells are prevented from entering T cell-dependent cell interaction areas within lymphoid organs. This state of T cell 'amnaesia' may underlie anergy in some inflammatory, infectious and neoplastic diseases. The apparent paradox of T cell-dependent tumour regression occurring in mice with depressed T cell responses is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235074      PMCID: PMC1536085     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  A comparative study of anaerobic Coryneforms. Attempts to correlate their anti-tumour activity with their serological properties and ability to stimulate the lymphoreticular system.

Authors:  W H McBride; J Dawes; N Dunbar; A Ghaffar; M F Woodruff
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

2.  Simultaneous stimulation of plaque forming cells and depression of cellular immunity to sheep erythrocytes, after adjuvant treatment.

Authors:  L Toujas; L Dazord; A Martin; J Guelfi
Journal:  Biomedicine       Date:  1973-11-20

3.  The effect of Corynebacterium parvum on the structure and function of the lymphoid system in mice.

Authors:  J E Castro
Journal:  Eur J Cancer       Date:  1974-02       Impact factor: 9.162

4.  Complete regressions of an established murine fibrosarcoma induced by systemic application of Corynebacterium granulosum.

Authors:  L Milas; N Hunter; I Basić; H R Withers
Journal:  Cancer Res       Date:  1974-10       Impact factor: 12.701

5.  Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.

Authors:  M T Scott
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

6.  Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.

Authors:  M T Scott
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

7.  The growth of tumours in T-cell deprived mice and their response to treatment with Corynebacterium parvum.

Authors:  M Woodruff; N Dunbar; A Ghaffar
Journal:  Proc R Soc Lond B Biol Sci       Date:  1973-08-31

8.  Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum.

Authors:  H Kirchner; H T Holden
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

9.  Combination of C. parvum and specific immunization against artificial pulmonary metastases in mice.

Authors:  L Milas; H D Kogelnik; I Basic; K Mason; N Hunter; H R Withers
Journal:  Int J Cancer       Date:  1975-11-15       Impact factor: 7.396

10.  Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.

Authors:  K Moore; W H McBride
Journal:  Br J Cancer       Date:  1983-06       Impact factor: 7.640

View more
  4 in total

1.  Incidence and growth of methylcholanthrene-induced tumors in mice with altered immunological status.

Authors:  C Trutin-Ostović; M Golubić; M Matović; M Marusić
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 2.  A Century of Radiation Therapy and Adaptive Immunity.

Authors:  Dörthe Schaue
Journal:  Front Immunol       Date:  2017-04-11       Impact factor: 7.561

3.  Induction of tolerance to a murine fibrosarcoma in two zones of dosage--the involvement of suppressor cells.

Authors:  W H McBride; S E Howie
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

4.  Tumor Size Matters-Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy.

Authors:  Jean Philippe Nesseler; Mi-Heon Lee; Christine Nguyen; Anusha Kalbasi; James W Sayre; Tahmineh Romero; Philippe Nickers; William H McBride; Dörthe Schaue
Journal:  Cancers (Basel)       Date:  2020-03-18       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.